EFFECT OF COLESTIPOL AND CLOFIBRATE ON PLASMA LIPID AND LIPOPROTEIN LEVELS IN TYPE-II B-HYPERLIPOPROTEINEMIA

被引：0
|
作者：
BELL, C [1 ]
OLSON, L [1 ]
HUNNINGHAKE, D [1 ]
机构：
[1] UNIV MINNESOTA,MINNEAPOLIS,MN 55455
来源：
CLINICAL RESEARCH | 1978年 / 26卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A644 / A644
页数：1
相关论文
共 50 条
  • [41] EFFECT OF CHOLESTYRAMINE (QUESTRAN), 8 G TWICE-DAILY, ON SERUM LIPOPROTEIN CONCENTRATIONS IN TYPE-II HYPERLIPOPROTEINEMIA
    OLSSON, AG
    PHARMATHERAPEUTICA, 1977, 1 (09) : 583 - 587
  • [42] LONG-TERM THERAPY HYPERLIPOPROTEINEMIA [TYPE-II A, II B, III AND IV] WITH CLOFIBRATE IN RESPECT TO TOLERANCE AND SIDE-EFFECTS .2.
    SCHWARTZKOPFF, W
    HOFFMANN, H
    RUSS, E
    HERZ KREISLAUF, 1973, 5 (12): : 525 - +
  • [43] PLASMA-LIPID LOWERING ACTIVITY OF ACIPIMOX IN PATIENTS WITH TYPE-II AND TYPE-IV HYPERLIPOPROTEINEMIA - RESULTS OF A MULTICENTER TRIAL
    CREPALDI, G
    AVOGARO, P
    DESCOVICH, GC
    DIPERRI, T
    POSTIGLIONE, A
    SIRTORI, CR
    STRANO, A
    VENTURA, S
    MUSATTI, L
    ATHEROSCLEROSIS, 1988, 70 (1-2) : 115 - 121
  • [44] INCREASED PLASMA-FIBRINOGEN AND PLATELET-AGGREGATES IN TYPE-II HYPERLIPOPROTEINEMIA
    LOWE, GDO
    DRUMMOND, MM
    THIRD, JLHC
    BREMNER, WF
    FORBES, CD
    PRENTICE, CRM
    LAWRIE, TDV
    THROMBOSIS AND HAEMOSTASIS, 1980, 42 (05) : 1503 - 1507
  • [45] EFFECT OF THE PURIFIED UNSAPONIFIABLE FRACTION OF SOYBEAN ON PRIMARY TYPE-II HYPERLIPOPROTEINEMIA
    NAKASHIMA, Y
    NAKAMURA, T
    ARAMAKI, Y
    KUROIWA, A
    ARTERY, 1983, 12 (03) : 199 - 211
  • [46] EFFECTS OF SIMVASTATIN ON PLASMA-LIPOPROTEIN SUBFRACTIONS, CHOLESTEROL ESTERIFICATION RATE, AND CHOLESTERYL ESTER TRANSFER PROTEIN IN TYPE-II HYPERLIPOPROTEINEMIA
    HOMMA, Y
    OZAWA, H
    KOBAYASHI, T
    YAMAGUCHI, H
    SAKANE, H
    NAKAMURA, H
    ATHEROSCLEROSIS, 1995, 114 (02) : 223 - 234
  • [47] LIPID PEROXIDE LEVELS IN TYPE-II HYPERLIPOPROTEINEMIC SUBJECTS
    KAMEDATAKEMURA, K
    CORDER, CN
    LEE, DM
    ARTERY, 1993, 20 (04) : 189 - 200
  • [48] IMPROVEMENT OF LIPOPROTEIN LIPID-COMPOSITION IN TYPE-II DIABETIC-PATIENTS WITH CONCOMITANT HYPERLIPOPROTEINEMIA BY ACIPIMOX TREATMENT - RESULTS OF A MULTICENTER TRIAL
    KOEV, D
    ZLATEVA, S
    SUSIC, M
    BABIC, D
    PROFOZIC, V
    SKRABALO, Z
    LANGROVA, H
    CVRKALOVA, AL
    RAJECOVA, E
    KLIMES, I
    SEBOKOVA, E
    HANZEN, E
    LACKO, A
    KREZE, A
    RYBKA, J
    GUS, M
    KALITS, I
    KARADI, I
    ROMICS, L
    LEOWSKI, J
    ORLANDINI, L
    DIABETES CARE, 1993, 16 (09) : 1285 - 1290
  • [49] ALFALFA SEEDS LOWER LOW-DENSITY-LIPOPROTEIN CHOLESTEROL AND APOLIPOPROTEIN-B CONCENTRATIONS IN PATIENTS WITH TYPE-II HYPERLIPOPROTEINEMIA
    MOLGAARD, J
    VONSCHENCK, H
    OLSSON, AG
    ATHEROSCLEROSIS, 1987, 65 (1-2) : 173 - 179
  • [50] EFFECT OF CLOFIBRATE ON ELIMINATION OF CHOLESTEROL AS BILE-ACIDS IN PATIENTS WITH HYPERLIPOPROTEINEMIA TYPE II AND IV
    EINARSSO.K
    HELLSTRO.K
    KALLNER, M
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1973, 3 (04) : 345 - 351
12345